Pulous, Fadi E. http://orcid.org/0000-0002-0794-8078
Cruz-Hernández, Jean C.
Yang, Chongbo
Kaya, Ζeynep
Paccalet, Alexandre http://orcid.org/0000-0002-6331-562X
Wojtkiewicz, Gregory http://orcid.org/0000-0002-3148-8411
Capen, Diane
Brown, Dennis
Wu, Juwell W.
Schloss, Maximilian J.
Vinegoni, Claudio http://orcid.org/0000-0002-9818-3639
Richter, Dmitry
Yamazoe, Masahiro
Hulsmans, Maarten http://orcid.org/0000-0003-1009-658X
Momin, Noor
Grune, Jana
Rohde, David http://orcid.org/0000-0002-3785-9375
McAlpine, Cameron S.
Panizzi, Peter
Weissleder, Ralph
Kim, Dong-Eog
Swirski, Filip K. http://orcid.org/0000-0002-3163-9152
Lin, Charles P. http://orcid.org/0000-0002-7450-627X
Moskowitz, Michael A. http://orcid.org/0000-0002-9052-4937
Nahrendorf, Matthias http://orcid.org/0000-0002-4021-1887
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NS108419)
Article History
Received: 19 October 2021
Accepted: 23 March 2022
First Online: 2 May 2022
Competing interests
: M.N. has received funds or material research support from Lilly, Alnylam, Biotronik, CSL Behring, GlycoMimetics, GSK, Medtronic, Novartis and Pfizer, as well as consulting fees from Biogen, Gimv, IFM Therapeutics, Molecular Imaging, Sigilon, NovoNordisk and Verseau Therapeutics. The other authors declare no competing interests.